|
|
0 1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Æ Ø Å
Ønsker du salgsvekst?
B2B Connect er en plattform hvor bedrifter som trenger salgsmøter kan benytte seg av så mange profesjonelle møtebookere de ønsker, fra en stor pool.
Du betaler kun per booket (og gjennomført) salgsmøte, og pris per salgsmøte bestemmer du selv. Det er ingen bindinger, og ingen oppstarts- eller abonnementsavgift. Prøve oss med kun 3 møter?
| Navn | Pe United AS |
|---|---|
| Orgnr/født år | 988522651 |
| Ant aksjer | 1 |
| Omsetning | 0 |
| Driftsresultat | -82 |
| Egenkapital | 51,341 |
| Ant.eiere | 1 |
| Navn | Orgnr/født år | Aksjeklasse | Ant aksjer | Andel |
|---|---|---|---|---|
| Pål Erik Robinson | 1969 | Ordinære aksjer | 1 | 100.0% |
| Navn | Via | Ant aksjer | Andel | Egenkapital |
|---|---|---|---|---|
| Ingen registrert | ||||
| Navn | Ant aksjer | Andel | Omsetning* | Driftsresultat* | Egenkapital* | Ant.eiere |
|---|---|---|---|---|---|---|
| Ro Invest AS | 9,220 | 100.0% | 0 | -1,097 | 55,576 | 1 |
| Spir Group ASA | 231,438 | 0.2% | 43 | -43 | 1,785 | 992 |
| Link Mobility Group Holding ASA | 152,569 | 0.1% | -4 | 3,798 | 3,924 | |
| Pexip Holding ASA | 50,000 | 0.0% | -9 | 713 | 5,370 | |
| Nykode Therapeutics ASA | 50,000 | 0.0% | 2 | -9 | 27 | 7,455 |
| Kitron ASA | 30,000 | 0.0% | 29 | -5 | 115 | 10,511 |
| Crayon Group Holding ASA | 8,000 | 0.0% | -3 | 169 | 5,871 | |
| Tgs ASA | 7,000 | 0.0% | 9 | 2 | 11 | 5,954 |
* Justert for eierandel
| Navn | Ant aksjer | Andel | Omsetning* | Driftsresultat* | Egenkapital* | Ant.eiere |
|---|---|---|---|---|---|---|
| Nextera AS
Via Ro Invest AS |
227,773 | 6.2% | 787 | -2,520 | 921 | 52 |
| Zelluna Immunotherapy AS
Via Ro Invest AS |
528,196 | 4.4% | 344 | -4,100 | 5,391 | 41 |
| Apim Therapeutics AS
Via Ro Invest AS |
27,807 | 1.7% | 0 | -320 | 1,021 | 143 |
| Alliance Venture Spring AS
Via Ro Invest AS |
3,520,479 | 0.7% | 21 | -65 | 2,322 | 54 |
| Novelda AS
Via Ro Invest AS |
10,491 | 0.6% | 88 | -963 | 717 | 195 |
| Iphone AS
Via Ro Invest AS |
270,286 | 0.3% | 2 | 1 | 5 | 98 |
| Ambita AS
Via Spir Group ASA |
107 | 0.2% | 815 | 110 | 565 | 1 |
| Sikri AS
Via Spir Group ASA |
53 | 0.2% | 491 | 59 | 179 | 1 |
| Thor Medical ASA
Via Ro Invest AS |
400,000 | 0.2% | 0 | -7 | 470 | 10,877 |
| Oncoinvent ASA
Via Ro Invest AS |
33,000 | 0.2% | 10 | -251 | 93 | 446 |
| Bergenbio ASA
Via Ro Invest AS |
4,000,000 | 0.1% | 2 | -285 | 189 | 14,902 |
| Eam Solar AS
Via Ro Invest AS |
10,000 | 0.1% | 19 | -2 | 47 | 2,812 |
| Akastor ASA
Via Ro Invest AS |
210,000 | 0.1% | 7 | -25 | 2,800 | 8,204 |
| Panoro Energy ASA
Via Ro Invest AS |
80,000 | 0.1% | 4 | 146 | 5,987 | |
| Link Mobility Group AS | 7,753 | 0.1% | 141 | -83 | 2,280 | 1 |
| Pexip AS | 14 | 0.0% | 377 | -117 | 17 | 1 |
| Crayon Group Holding ASA
Via Ro Invest AS |
32,000 | 0.0% | -11 | 676 | 5,871 | |
| Nykode Therapeutics ASA
Via Ro Invest AS |
100,000 | 0.0% | 4 | -17 | 53 | 7,455 |
| Tgs ASA
Via Ro Invest AS |
30,000 | 0.0% | 37 | 8 | 47 | 5,954 |
| Link Mobility Group Holding ASA
Via Ro Invest AS |
65,000 | 0.0% | -2 | 1,619 | 3,924 | |
| Kitron AS
Via Kitron ASA |
7 | 0.0% | 277 | 26 | 45 | 1 |
| Crayon Group AS | 12,350 | 0.0% | 52 | -12 | 112 | 1 |
| Magseis Fairfield AS
Via Tgs ASA |
14,488 | 0.0% | 2 | -1 | 7 | 1 |
| Tgs Ap Investments AS
Via Tgs ASA |
0 | 0.0% | 2 | 0 | 1 | 1 |
| Tgs Newco AS
Via Tgs ASA |
0 | 0.0% | 0 | 1 | ||
| Tgs AS
Via Tgs ASA |
2 | 0.0% | 1 | 0 | -1 | 1 |
| Tgs Nes AS
Via Tgs ASA |
5 | 0.0% | 0 | -1 | 26 | 1 |
| Pexip Holding ASA | 1,361 | 0.0% | -0 | 19 | 5,370 | |
| Aker Bp ASA
Via Ro Invest AS |
6,000 | 0.0% | 123 | 81 | 111 | 36,633 |
| Crayon Group Holding ASA | 118 | 0.0% | -0 | 2 | 5,871 | |
| Spir Group ASA
Via Spir Group ASA |
4 | 0.0% | 0 | -0 | 0 | 992 |
| Tgs ASA
Via Tgs ASA |
22 | 0.0% | 0 | 0 | 0 | 5,954 |
| Link Mobility Group Holding ASA | 3 | 0.0% | -0 | 0 | 3,924 |
* Justert for eierandel
